Edition:
India

Biomarin Pharmaceutical Inc (BMRN.OQ)

BMRN.OQ on NASDAQ Stock Exchange Global Select Market

74.43USD
30 Oct 2020
Change (% chg)

$0.01 (+0.01%)
Prev Close
$74.42
Open
$73.74
Day's High
$74.54
Day's Low
$72.45
Volume
649,796
Avg. Vol
692,621
52-wk High
$131.86
52-wk Low
$68.25

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2020 Jun '20 429.48 -0.161
Mar '20 502.07 0.435
FY 2019 Dec '19 454.44 0.084
Sep '19 461.10 0.296
Jun '19 387.76 -0.209
Mar '19 400.74 -0.317
FY 2018 Dec '18 353.21 0.005
Sep '18 391.71 -0.071
Jun '18 372.85 -0.095
Mar '18 373.45 -0.277
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-20 18 474.99 522.00 420.33 494.44
Quarter Ending Mar-21 7 482.21 514.00 466.78 539.79
Year Ending Dec-20 22 1,859.54 1,917.00 1,800.64 1,946.00
Year Ending Dec-21 22 2,035.42 2,324.00 1,867.60 2,204.40
Earnings (per share)
Quarter Ending Dec-20 17 2.75 4.18 -0.33 -0.05
Quarter Ending Mar-21 6 0.02 0.19 -0.03 0.36
Year Ending Dec-20 20 4.18 4.93 3.62 0.21
Year Ending Dec-21 20 0.51 2.50 -0.54 1.06
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 113.98 33.33 42.75
P/E High - Last 5 Yrs. -- 43.30 46.69
P/E Low - Last 5 Yrs. -- 25.39 25.34
Beta 0.69 0.86 0.85
Price to Sales (TTM) 7.31 4.03 11.39
Price to Book (MRQ) 4.17 3.78 4.25
Price to Tangible Book (MRQ) 5.18 4.37 5.74
Price to Cash Flow (TTM) 58.22 20.20 33.67
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.66 1.53
Dividend Yield - 5 Year Avg -- 1.61 1.50
Dividend 5 Year Growth Rate -- 4.25 5.03
Payout Ratio(TTM) 0.00 46.98 44.04

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 10.76 0.78 -0.33
Sales (TTM) vs TTM 1 Yr. Ago 20.46 5.02 4.99
Sales - 5 Yr. Growth Rate 17.86 5.90 6.19
EPS (MRQ) vs Qtr. 1 Yr. Ago 22.77 2.52 1.26
EPS (TTM) vs TTM 1 Yr. Ago 210.38 -- --
EPS - 5 Yr. Growth Rate -- 8.29 8.51
Capital Spending - 5 Yr. Growth Rate 6.90 13.24 13.08

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.34 2.49 2.53
Current Ratio (MRQ) 3.26 3.40 3.42
LT Debt to Equity (MRQ) 33.31 12.56 14.38
Total Debt to Equity (MRQ) 44.85 16.69 18.86
Interest Coverage (TTM) -4.54 11.28 14.74

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 78.23 54.49 54.40
Gross Margin - 5 Yr. Avg. 80.38 54.28 53.91
EBITD Margin (TTM) 5.18 -- --
EBITD - 5 Yr. Avg -8.29 18.91 11.68
Operating Margin (TTM) 3.19 15.37 -11.17
Operating Margin - 5 Yr. Avg. -17.70 14.62 5.37
Pre-Tax Margin (TTM) 3.20 15.82 -13.18
Pre-Tax Margin - 5 Yr. Avg. -19.33 14.91 5.14
Net Profit Margin (TTM) 6.62 12.03 -16.90
Net Profit Margin - 5 Yr. Avg. -15.01 11.24 1.74
Effective Tax Rate (TTM) -106.80 19.27 19.94
Effective Tax Rate - 5 Yr. Avg. -- 22.32 22.40

Efficiency

  Company industry sector
Revenue/Employee (TTM) 615,493 1,003,736,451 858,318,634
Net Income/Employee (TTM) 40,739 115,590,039 98,723,331
Receivable Turnover (TTM) 4.87 5.51 5.45
Inventory Turnover (TTM) 0.61 2.52 3.45
Asset Turnover (TTM) 0.38 0.80 0.78

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 2.52 10.19 9.45
Return on Assets - 5 Yr. Avg. -4.79 11.25 10.75
Return on Investment (TTM) 2.90 12.64 12.00
Return on Investment - 5 Yr. Avg. -5.56 14.08 13.46
Return on Equity (TTM) 3.95 14.16 13.74
Return on Equity - 5 Yr. Avg. -7.37 16.82 16.12
  1 Year 3 Year 5 Year
Sales % 14.27 15.12 17.86
EPS (TTM) % 69.45 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Biomarin Pharmaceutical Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -0.73 1.65 99 32
13 Week -37.88 -37.85 27 20
26 Week -15.54 -26.88 76 23
52 Week 1.67 -5.56 99 56
YTD -11.97 -13.02 99 55
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 781
Total Shares Held: 184,261,092
3 Mo. Net Change: 971,721
# New Positions: 21
# Closed Positions: 23
# Increased Positions: 93
# Reduced Positions: 79
# Net Buyers: 14
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.